BioSpace News Archive

Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company, announced today three poster presentations from scientific collaborators at the upcoming American Association for Cancer Research (AACR) Annual Meeting, taking place April 14-19, 2023, in Orlando, Florida.

Mainz Biomed N.V. announced financial results for the fiscal year ended December 31, 2022.

Theravance Biopharma, Inc. will present at the 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17 at 3:45 pm ET.

Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to report first quarter 2023 financial results after the close of trading on Monday, May 1.

Cara Therapeutics, Inc. today announced that Christopher Posner, President and Chief Executive Officer, will present a company overview at the 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2023, at 1:30 p.m. EDT.

Can-Fite BioPharma Ltd today announced that it received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) with respect to the submission of a registration plan for a pivotal Phase III clinical trial for the treatment of moderate to severe psoriasis.

Organogenesis Holdings Inc. today announced that first quarter of fiscal year 2023 financial results will be reported after the market closes on Wednesday, May 10th.

Denali Therapeutics Inc. today announced that new data from the 28-day treatment period of the Phase 1b study of DNL343 in participants with amyotrophic lateral sclerosis (ALS) will be presented at the 75th Annual Meeting of the American Academy of Neurology (AAN), which will be held April 22-27, 2023, in Boston, Massachusetts.

Mirum Pharmaceuticals, Inc. announced that on April 10, 2023, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 25,950 shares of common stock and 12,960 restricted stock units to five new employees under Mirum’s 2020 Inducement Plan.

SK Biopharmaceuticals, an innovative global pharmaceuticals company, announced that its digital wearable devices – Zero WiredTM and Zero EarbudsTM – have won the Red Dot Design Award 2023 in the healthcare category for outstanding design.